A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee
Completed · Phase 2 · Has a placebo group
Conditions studied: Osteoarthritis of the Knee
In brief
This is a Phase 2 study, involving a 4-week treatment period, designed to test the ability of investigational study drug ARRY-371797 to reduce pain in patients with moderate to severe pain due to osteoarthritis (OA) of the knee, and to further evaluate the drug's safety. Approximately 150 patients from the US will be enrolled in this study.
Key facts
- Study ID
- NCT01366014
- Run by
- Pfizer
- People needed
- 157
- Starts
- 2011-06-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2020-10-14
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pfizer Investigational Site — Phoenix, Arizona, United States
- Pfizer Investigational Site — Fort Lauderdale, Florida, United States
- Pfizer Investigational Site — Pinellas Park, Florida, United States
- Pfizer Investigational Site — Sarasota, Florida, United States
- Pfizer Investigational Site — Watertown, Massachusetts, United States
- Pfizer Investigational Site — Olive Branch, Mississippi, United States
- Pfizer Investigational Site — Charlotte, North Carolina, United States
- Pfizer Investigational Site — Raleigh, North Carolina, United States
- Pfizer Investigational Site — Winston-Salem, North Carolina, United States
- Pfizer Investigational Site — Duncansville, Pennsylvania, United States
- Pfizer Investigational Site — Austin, Texas, United States
- Pfizer Investigational Site — Salt Lake City, Utah, United States
- Pfizer Investigational Site — Kenosha, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.